We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Maxcyte Inc | LSE:MXCT | London | Ordinary Share | COM STK USD0.01 (DI) |
| Price Change | % Change | Share Price | Bid Price | Offer Price | |
|---|---|---|---|---|---|
| -8.00 | -2.75% | 283.00 | 280.00 | 286.00 |
| High Price | Low Price | Open Price | Shares Traded | Last Trade |
|---|---|---|---|---|
| 292.00 | 283.00 | 292.00 | 14,288 | 15:41:47 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Biological Pds,ex Diagnstics | 41.29M | -37.92M | -0.3664 | -10.26 | 301.2M |
| Date | Time | Source | Headline |
|---|---|---|---|
| 03/10/2024 | 09:41 | UK RNS | MaxCyte, Inc. Exercise of options and PDMR dealing |
| 01/10/2024 | 09:47 | UK RNS | MaxCyte, Inc. Exercise of options and PDMR dealing |
| 01/10/2024 | 07:00 | UK RNS | MaxCyte, Inc. Total Voting Rights |
| 27/9/2024 | 16:15 | UK RNS | MaxCyte, Inc. Holding(s) in Company |
| 27/9/2024 | 15:29 | UK RNS | MaxCyte, Inc. Holding(s) in Company |
| 20/9/2024 | 17:02 | UK RNS | MaxCyte, Inc. Holding(s) in Company |
| 16/9/2024 | 10:33 | ALNC |  MaxCyte touts strategic platform license deal with Kamau Therapeutics |
| 16/9/2024 | 07:00 | UK RNS | MaxCyte, Inc. TR-1: Notification of major holdings |
| 16/9/2024 | 07:00 | UK RNS | MaxCyte, Inc. Signing of Strategic Platform License |
| 06/9/2024 | 17:07 | UK RNS | MaxCyte, Inc. Exercise of options and PDMR dealing |
1 Year Maxcyte Chart |
Intraday Maxcyte Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
